NCT00420966View on ClinicalTrials.gov

Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy

CompletedOBSERVATIONAL

Enrollment

25,003

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

June 26, 2017

Study Completion Date

June 26, 2017

Conditions

Lower Respiratory Tract InfectionRespiratory Syncytial Virus Infections

Trial Locations (2)

T3B 6A8

Alberta Children's Hospital, Calgary

L8N 3Z5

McMaster Children's Hospital, Hamilton

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Abbott

INDUSTRY

lead

Sunnybrook Health Sciences Centre

OTHER